PATENT CLAIM ANALYSIS

Application Number: 15748145
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "04400R"]

Abstract:
The present invention relates to an expression system for enzyme replacement therapy with the aim of obtaining or maintaining a steady level of L-DOPA in the blood of an individual, achieved through systemic administration of the expression system. The invention is thus useful in the treatment of catecholamine deficient disorders, such as dopamine deficient disorders including Parkinson's Disease.

Claim (Index 133):
The expression system according to  claim 132 , further comprising a linker between the polynucleotide sequences encoding P1 and P2, and a linker between the polynucleotide sequences encoding P2 and P3, optionally wherein the linker is an Internal Ribosome Entry Site (IRES).

Metadata:
- Claim Count in Document: 27.0
- Percentile: 86.0
- Lexical Diversity: 1.36957
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14242648', '10096723', '10285308', '10408456', '15550864']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7579010616495683
- 35 USC 102 Novelty (BERT): 0.5670706320937225
- Combined Prediction Score: 0.7388180186939837
- Mean Citation Score: 310.8961020000001
- Max Citation Score: 494.30365
- Similarity Product: 343.9581969071984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test